Maravai Lifesciences Holdings (MRVI) Interest Expenses (2020 - 2026)

Maravai Lifesciences Holdings' Interest Expenses history runs 7 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• On a quarterly basis, Interest Expenses fell 76.48% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $37.6 million, a 43.78% increase from a year earlier, with the FY2025 full-year figure at $34.5 million, down 95.03% from the prior year.
• Interest Expenses slipped to $6.1 million in Q1 2026 per MRVI's latest filing, from $8.2 million in the prior quarter.
• Across five years, Interest Expenses topped out at $26.2 million in Q3 2025 and bottomed at $6.1 million in Q1 2026.
• The 5-year median for Interest Expenses is $24.4 million (2022), against an average of $19.5 million.
• Across the five-year window, Interest Expenses jumped 119.59% in 2025 and slumped 76.48% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $10.0 million in 2022, then jumped by 54.56% to $15.4 million in 2023, then fell by 26.86% to $11.3 million in 2024, then slipped by 27.01% to $8.2 million in 2025, then slipped by 25.24% to $6.1 million in 2026.
• Per Business Quant, the three latest MRVI Interest Expenses figures stand at $6.1 million (Q1 2026), $8.2 million (Q4 2025), and $26.2 million (Q3 2025).